Pro Medicus is one of the most interesting companies on the ASX - and one of the best performing stocks, having risen around 1,000% in the last five years. Yesterday, the medical imaging software company announced record revenue and profit, off the back of a stack of new contracts, particularly in the US. But while its share price initially rose, it closed down more than three per cent - a consequence of the stock being priced to perfection, and the result being just a touch below expectations. Dr Sam Hupert speaks to Ausbiz's Nadine Blayney about the result, staying ahead of the competition, and succession planning at the business he co-founded 40 years ago. Fear & Greed is proud to partner with Ausbiz, Australia's leading provider of live and on-demand video of the latest news in Australian business, markets, economy and startups. Sign up for free at ausbiz.com.au You can watch this interview with Dr Sam Hupert here.Find out more: https://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.